Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis

Instituto Mexicano del Seguro Social

Status and phase: Completed; Phase 3

Conditions: Shoulder Arthritis

Treatments: Drug: Lidocaine 2% Injectable Solution; Drug: Methylprednisolone Acetate; Drug: Ropivacaine HCl Inj 7.5 MG/ML

Study type: Interventional

Funder types: Other

Identifiers

NCT03794505

F-2018-3401-056

Details and patient eligibility

About

Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis

Full description

To describe the efficacy in pain management and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in patients with glenohumeral arthritis

Enrollment: 40 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• IMSS affiliated
• Glenohumeral arthritis diagnosed

Exclusion criteria

• Previusly treatment for the same disease
• No follow up
• Dead

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

40 participants in 2 patient groups

Shoulder infiltration

Active Comparator group

Description:

Shoulder infiltration using 2 ml of Lidocaine 2% Injectable Solution and methylprednisolone acetate 40 mg

Treatment:

Drug: Methylprednisolone Acetate

Drug: Lidocaine 2% Injectable Solution

Suprascapular nerve block

Experimental group

Description:

Suprascapular nerve block ultrasound guided using 25 mg of Ropivacaine HCl Inj 7.5 MG/ML and methylprednisolone acetate 40 mg

Treatment:

Drug: Ropivacaine HCl Inj 7.5 MG/ML

Drug: Methylprednisolone Acetate